Dr Mohamed Sharafeldin received a funding grant to develop novel device for breast cancer diagnosis in collaboration with Prof. Jason J. Davis at University of Oxford.
The device employs electrochemical immunoassay to selectively recruit and quantify biomarkers specific to breast cancer from blood samples